“It is by far the most significant development in the plant-made pharmaceuticals arena right now.” Viral vectors have enough going for them that the technique could become a staple for protein ...

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

Kobayashi Pharmaceutical also has a plant in Wakayama Prefecture where the ... Puberulic acid is a natural compound made from blue mold and has antibiotic properties, making it effective in ...

The plants make hundreds of critical medicines, including antibiotics ... pressure to cut their costs and some will do that by cutting quality,” said David Ridley of Duke University, who studies the ...

By John Lee. Prime Minister Mohammed S. Al-Sudani has inaugurated the new "Hydrogen" Pharmaceutical Plant in Karbala Governorate, specializing in the production of cancer treatment medications. The ...

Three of Lilly's new plants will be used to manufacture pharmaceutical raw ingredients, while the fourth will make injectable medicines, the drugmaker said.

The new plants will be built over the next five years, and are expected to create more than 3,000 jobs for skilled workers.